These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34602548)

  • 1. Accumulation of Toxic Advanced Glycation End-Products Induces Cytotoxicity and Inflammation in Hepatocyte-Like Cells Differentiated from Human Induced Pluripotent Stem Cells.
    Kikuchi C; Sakasai-Sakai A; Okimura R; Tanaka H; Takata T; Takeuchi M; Matsunaga T
    Biol Pharm Bull; 2021; 44(10):1399-1402. PubMed ID: 34602548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular Toxic Advanced Glycation End-Products Promote the Production of Reactive Oxygen Species in HepG2 Cells.
    Sakasai-Sakai A; Takata T; Takeuchi M
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32660150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Relevance of Toxic AGEs (TAGE) Cytotoxicity to NASH Pathogenesis: A Mini-Review.
    Sakasai-Sakai A; Takata T; Takino JI; Takeuchi M
    Nutrients; 2019 Feb; 11(2):. PubMed ID: 30813302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of Intracellular TAGE and the TAGE-RAGE-ROS Axis in the Onset and Progression of NAFLD/NASH.
    Sakasai-Sakai A; Takeda K; Takeuchi M
    Antioxidants (Basel); 2023 Mar; 12(3):. PubMed ID: 36978995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategies.
    Takeuchi M; Takino J; Sakasai-Sakai A; Takata T; Ueda T; Tsutsumi M; Hyogo H; Yamagishi S
    World J Hepatol; 2014 Dec; 6(12):880-93. PubMed ID: 25544875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of intracellular glyceraldehyde-derived advanced glycation end-products on human hepatocyte cell death.
    Sakasai-Sakai A; Takata T; Takino JI; Takeuchi M
    Sci Rep; 2017 Oct; 7(1):14282. PubMed ID: 29079763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular Toxic AGEs (TAGE) Triggers Numerous Types of Cell Damage.
    Takeuchi M; Sakasai-Sakai A; Takata T; Takino JI; Koriyama Y; Kikuchi C; Furukawa A; Nagamine K; Hori T; Matsunaga T
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33808036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of toxic AGEs (TAGE) may be a promising novel biomarker in development and progression of NASH.
    Takeuchi M; Sakasai-Sakai A; Takata T; Ueda T; Takino J; Tsutsumi M; Hyogo H; Yamagishi S
    Med Hypotheses; 2015 May; 84(5):490-3. PubMed ID: 25697114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nonalcoholic fatty liver disease model in human induced pluripotent stem cell-derived hepatocytes, created by endoplasmic reticulum stress-induced steatosis.
    Parafati M; Kirby RJ; Khorasanizadeh S; Rastinejad F; Malany S
    Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30254132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinoma.
    Takino J; Nagamine K; Hori T; Sakasai-Sakai A; Takeuchi M
    World J Hepatol; 2015 Oct; 7(23):2459-69. PubMed ID: 26483867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular Toxic Advanced Glycation End-Products in 1.4E7 Cell Line Induce Death with Reduction of Microtubule-Associated Protein 1 Light Chain 3 and p62.
    Takata T; Sakasai-Sakai A; Takeuchi M
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an FXR-modulated liver-intestine hybrid state in iPSC-derived hepatocyte-like cells.
    Nell P; Kattler K; Feuerborn D; Hellwig B; Rieck A; Salhab A; Lepikhov K; Gasparoni G; Thomitzek A; Belgasmi K; Blüthgen N; Morkel M; Küppers-Munther B; Godoy P; Hay DC; Cadenas C; Marchan R; Vartak N; Edlund K; Rahnenführer J; Walter J; Hengstler JG
    J Hepatol; 2022 Nov; 77(5):1386-1398. PubMed ID: 35863491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist c-Met Monoclonal Antibody Augments the Proliferation of hiPSC-derived Hepatocyte-Like Cells and Improves Cell Transplantation Therapy for Liver Failure in Mice.
    Yuan L; Zhang Y; Liu X; Chen Y; Zhang L; Cao J; Li X; Wang M; Wu K; Zhang J; Liu G; Tang Q; Yuan Q; Cheng T; Xia N
    Theranostics; 2019; 9(7):2115-2128. PubMed ID: 31037160
    [No Abstract]   [Full Text] [Related]  

  • 14. Suppression of Hepatic Stellate Cell Death by Toxic Advanced Glycation End-Products.
    Takino JI; Sato T; Nagamine K; Sakasai-Sakai A; Takeuchi M; Hori T
    Biol Pharm Bull; 2021; 44(1):112-117. PubMed ID: 33390537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. hiPSC-derived hepatocytes closely mimic the lipid profile of primary hepatocytes: A future personalised cell model for studying the lipid metabolism of the liver.
    Kiamehr M; Alexanova A; Viiri LE; Heiskanen L; Vihervaara T; Kauhanen D; Ekroos K; Laaksonen R; Käkelä R; Aalto-Setälä K
    J Cell Physiol; 2019 Apr; 234(4):3744-3761. PubMed ID: 30146765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte-like cells derived from human induced pluripotent stem cells using small molecules: implications of a transcriptomic study.
    Gao X; Li R; Cahan P; Zhao Y; Yourick JJ; Sprando RL
    Stem Cell Res Ther; 2020 Sep; 11(1):393. PubMed ID: 32917265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Chimeric Humanized Mouse Model by Engrafting the Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cell for the Chronic Hepatitis B Virus Infection.
    Yuan L; Liu X; Zhang L; Li X; Zhang Y; Wu K; Chen Y; Cao J; Hou W; Zhang J; Zhu H; Yuan Q; Tang Q; Cheng T; Xia N
    Front Microbiol; 2018; 9():908. PubMed ID: 29867819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research advances in hepatocyte-like cells from human induced pluripotent stem cells and their application].
    Cao YY; Zeng X
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jan; 26(1):69-72. PubMed ID: 29804367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for Toxic Advanced Glycation End-Products Generated in the Normal Rat Liver.
    Takata T; Sakasai-Sakai A; Takino JI; Takeuchi M
    Nutrients; 2019 Jul; 11(7):. PubMed ID: 31315223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of intracellular toxic advanced glycation end-products (TAGE) on murine myoblast cell death.
    Takata T; Sakasai-Sakai A; Takeuchi M
    Diabetol Metab Syndr; 2020; 12():54. PubMed ID: 32684984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.